4.6 Article

Soluble Isoforms of Vascular Endothelial Growth Factor Are Predictors of Response to Sunitinib in Metastatic Renal Cell Carcinomas

Related references

Note: Only part of the references are listed.
Article Oncology

Sorafenib for Older Patients With Renal Cell Carcinoma: Subset Analysis From a Randomized Trial

Tim Eisen et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)

Article Oncology

Efficacy of sunitinib and sorafenib in metastatic papillary and chromophobe renal cell carcinoma

Toni K. Choueiri et al.

JOURNAL OF CLINICAL ONCOLOGY (2008)

Letter Oncology

Hypertension as a predictive factor of Sunitinib activity

O. Rixe et al.

ANNALS OF ONCOLOGY (2007)

Article Medicine, General & Internal

Sunitinib versus interferon alfa in metastatic renal-cell carcinoma

Robert J. Motzer et al.

NEW ENGLAND JOURNAL OF MEDICINE (2007)

Article Oncology

Cancer statistics, 2006

A Jemal et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2006)

Review Biochemistry & Molecular Biology

The biology of VEGF and its receptors

N Ferrara et al.

NATURE MEDICINE (2003)

Review Biochemistry & Molecular Biology

Angiogenesis in health and disease

P Carmeliet

NATURE MEDICINE (2003)

Article Oncology

New guidelines to evaluate the response to treatment in solid tumors

F Duffaud et al.

BULLETIN DU CANCER (2000)

Article Oncology

New guidelines to evaluate the response to treatment in solid Tumors

P Therasse et al.

JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)